This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Helena Francis, PhD
VP of Corporate Development at Constructive Bio
Speaker

Profile

Helena supports Ola and the leadership team in growing a global synthetic biology leader. As Chief of Staff, Helena works across strategy, operations and corporate governance to build a strong team of genome writing pioneers and enable them to succeed.

Before joining Constructive, Helena completed her DPhil in Genetics and Synthetic Biology at the University of Oxford, where she focused on systematic genetic dissection of the alpha-globin gene cluster. She then carried out a stint as a Management Consultant in Oliver Wyman’s London office, working across a range of strategy, modelling and risk projects and most recently helped guide London-based biotechnology start-up Bactobio through two fundraises and six successful Innovate UK applications totalling £11 million as their Head of Business Development. Helena has an MSci/BA in Natural Sciences (Biochemistry) from the University of Cambridge.

Outside of work, Helena is an avid adventurer, be that hiking, cycling or scuba diving.

Agenda Sessions

  • Biology vs. New-to-nature Chemistries: Constructing the Next Generation of Therapeutic Peptides with An Expanded Genetic Code

    16:30